Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 10, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-017368.pdf 0001104659-21-017368.rtf View HTML
February 11, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000093751-21-000286.pdf 0000093751-21-000286.rtf View HTML
July 8, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000834237-22-010253.pdf 0000834237-22-010253.rtf View HTML
December 19, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000895345-22-000827.pdf 0000895345-22-000827.rtf View HTML
June 16, 2015	SC 13D/A	An amendment to a SC 13D filing	0001193125-15-224243.pdf 0001193125-15-224243.rtf View HTML
November 18, 2015	SC 13D/A	An amendment to a SC 13D filing	0001193125-15-380383.pdf 0001193125-15-380383.rtf 0001193125-15-380383.xls View HTML
January 20, 2016	SC 13D/A	An amendment to a SC 13D filing	0001144204-16-076141.pdf 0001144204-16-076141.rtf 0001144204-16-076141.xls View HTML
August 10, 2017	SC 13D/A	An amendment to a SC 13D filing	0001193125-17-254489.pdf 0001193125-17-254489.rtf 0001193125-17-254489.xls View HTML
July 3, 2018	SC 13D/A	An amendment to a SC 13D filing	0001193125-18-212523.pdf 0001193125-18-212523.rtf View HTML
December 21, 2018	SC 13D/A	An amendment to a SC 13D filing	0001144204-18-066059.pdf 0001144204-18-066059.rtf 0001144204-18-066059.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax